关注
Marcus R Kelly
Marcus R Kelly
在 ucsd.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities
K Han, SE Pierce, A Li, K Spees, GR Anderson, JA Seoane, YH Lo, ...
Nature 580 (7801), 136-141, 2020
2422020
The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery
M Toriyama, C Lee, SP Taylor, I Duran, DH Cohn, AL Bruel, JM Tabler, ...
Nature genetics 48 (6), 648-656, 2016
1512016
Drebrin restricts rotavirus entry by inhibiting dynamin-mediated endocytosis
B Li, S Ding, N Feng, N Mooney, YS Ooi, L Ren, J Diep, MR Kelly, ...
Proceedings of the National Academy of Sciences 114 (18), E3642-E3651, 2017
682017
Comparative proteomics reveals strain-specific β-TrCP degradation via rotavirus NSP1 hijacking a host Cullin-3-Rbx1 complex
S Ding, N Mooney, B Li, MR Kelly, N Feng, AV Loktev, A Sen, JT Patton, ...
PLoS pathogens 12 (10), e1005929, 2016
632016
A multi-scale map of cell structure fusing protein images and interactions
Y Qin, EL Huttlin, CF Winsnes, ML Gosztyla, L Wacheul, MR Kelly, ...
Nature 600 (7889), 536-542, 2021
572021
Interpretation of cancer mutations using a multiscale map of protein systems
F Zheng, MR Kelly, DJ Ramms, ML Heintschel, K Tao, B Tutuncuoglu, ...
Science 374 (6563), eabf3067, 2021
402021
Combined proteomic and genetic interaction mapping reveals new RAS effector pathways and susceptibilities
MR Kelly, K Kostyrko, K Han, NA Mooney, EE Jeng, K Spees, PT Dinh, ...
Cancer discovery 10 (12), 1950-1967, 2020
332020
Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth
R Tang, EG Shuldiner, M Kelly, CW Murray, JD Hebert, L Andrejka, ...
Nature cell biology 25 (1), 159-169, 2023
102023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma
K Kostyrko, M Román, AG Lee, DR Simpson, PT Dinh, SG Leung, ...
Nature communications 14 (1), 3966, 2023
92023
A multi-scale map of protein assemblies in the DNA damage response
A Kratz, M Kim, MR Kelly, F Zheng, CA Koczor, J Li, K Ono, Y Qin, ...
Cell Systems 14 (6), 447-463. e8, 2023
92023
University of Washington Center for Mendelian Genomics The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery
M Toriyama, C Lee, SP Taylor, I Duran, DH Cohn, AL Bruel, JM Tabler, ...
Nat. Genet 48, 648-656, 2016
72016
Duffourd Y, Faivre L, Rivière JB, Chen J, Liu KJ, Marcotte EM, Hildebrandt F, Thauvin-Robinet C, Krakow D, Jackson PK, Wallingford JB. The ciliopathy-associated CPLANE proteins …
M Toriyama, C Lee, SP Taylor, I Duran, DH Cohn, AL Bruel, JM Tabler, ...
Nat Genet 48, 648-56, 2016
62016
A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors
S Park, E Silva, A Singhal, MR Kelly, K Licon, I Panagiotou, C Fogg, ...
Nature Cancer, 1-14, 2024
22024
Multiplexed identification of RAS paralog imbalance as a driver of lung cancer growth
R Tang, EG Shuldiner, M Kelly, CW Murray, JD Hebert, L Andrejka, ...
bioRxiv, 2021.07. 08.451571, 2021
22021
WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis.
D Natwick, L Schiff, D McSwiggen, A Heckert, M Huey, H Morrison, M Loo, ...
Nature Communications 15 (1), 6059-6059, 2024
2024
WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis
F Rodríguez Pérez, D Natwick, L Schiff, D McSwiggen, A Heckert, M Huey, ...
Nature Communications 15 (1), 6059, 2024
2024
Abstract B25: Combined proteomic and genetic interaction mapping reveals new Ras pathway effectors and regulators
M Kelly, K Han, K Kostyrko, N Mooney, E Jeng, J Demeter, ...
Molecular Cancer Research 18 (5_Supplement), B25-B25, 2020
2020
Combinatorial knockout of Rap1GDS1 and RhoA leads to lethality in KRAS-driven non-small cell lung cancer.
K Kostyrko, M Kelly, K Han, E Jeng, D Morgens, M Bassik, P Jackson, ...
MOLECULAR CANCER RESEARCH 18 (5), 33-33, 2020
2020
Abstract PR07: Combinatorial knockout of Rap1GDS1 and RhoA leads to lethality in KRAS-driven non-small cell lung cancer
K Kostyrko, M Kelly, K Han, E Jeng, D Morgens, M Bassik, P Jackson, ...
Molecular Cancer Research 18 (5_Supplement), PR07-PR07, 2020
2020
Proteomic and Genomic Mapping of the RAS Pathway in Lung Adenocarcinoma
MR Kelly
Stanford University, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20